By clicking "Accept" on the Cookie banner, you give us your consent to store and access Cookies and Other Tracking Technologies as described in this Cookie Policy. Accept
About Us Company Profile Milestones Board of Directors Management Team Consultants R & D Pipeline Pulmonary Vascular L606 L608 Peripheral Vascular L608 Technology Sustained Release Inhalation Formulation Drug-Device Combination Scale-up Production Pressroom Press Release Campaigns Videos Publications Investors Corporate Governance Corporate Structure Board of Directors Others Corporate Governance Officer Corporate Governance Implementation ESG (Chinese Only) Information Security Management Intellectual Property Management Integrity management Sustainable Development Stakeholders Financial Information Financial Results Revenues Prospectuses Shareholder Information Annual General Meeting Major Shareholders Stock Affair Agent News & Events Press Releases Events and Presentations Material Information Careers Employee Welfare Environamental Friendliness Job Opening Home 中 EN
Publications ATS International Conference 2024 A Phase 3, 2-Part, Open-Label, Multicenter Study to Evaluate the safety and Efficacy of Liposomal Treprostinil Inhalation Suspension (L606) in Subjects with PAH and PH-ILD 2024-05-22 Link Pulmonary Vascular Research Institute (PVRI)2024 Annual Congress Clinical Pharmacokinetics of an Extended-Release Formulation of Inhaled Liposomal Treprostinil (L606) to Reduce Dosing Frequency 2024-02-02 Link ERS International Congress Extended Pulmonary Retention and Tissue Distribution of Inhaled Liposomal Iloprost (L608) 2022-09-04 Link ATS International Conference Multicompartment Modeling for Pulmonary Pharmacokinetics of Liposomal Treprostinil (L606) in Adults 2022-05-16 Link ERS Virtual International Congress A Multicompartmemt Simulation Predicts Pulmonary Pharmacokinetics of Inhaled Liposomal Treprostinil (L606) in Healthy Volunteer 2021-09-05 Link ATS International Conference 2021 Virtual Evaluation of Single Ascending-Dose Pharmacokinetics of Liposomal Treprostinil Inhalation Suspension (L606) in Healthy Volunteers 2021-05-14 Link ERS Virtual International Congress Inhaled Liposomal Treprostinil (L606) Shows Extended Release in Healthy Volunteer, And Prolongs Pharmacological Effect in Hypoxia-Induced Rat 2020-09-07 Link ATS International Conference Comparative Pharmacokinetics between Tyvaso® and L606, Extended-Release Formulation of Treprostinil for Inhalation Therapy 2020-05-15 Link ERS International Congress Inhaled Liposomal Iloprosts Extend Detectable Plasma Level and Prolong Reduction of Hypoxia-Induced Pulmonary Hypertension in Rat 2019-09-29 Link PHPN Symposium Preclinical and Clinical Pharmacokinetics of L606, An Extended-Release Formulation of Treprostinil for Inhalation Therapy. 2019-09-06 Link ATS International Conference Extended Release of Inhaled Liposomal Treprostinil Able to Prolong and Enhance Reduction of Pulmonary Arterial Pressure in Hypoxia-Induced Rats. 2019-05-21 Link ERS International Congress Inhaled Liposomal Iloprost Shows High Drug Encapsulation, Extended Release Profile and Potentials of Improving Patient Compliance 2018-09-17 Link ATS International Conference Inhaled Liposomal Treprostinil Shows Sustained Pharmacokinetic Profile, Lower Irritation, and Potentials of Reducing Dosing Frequency 2018-05-21 Link